ad

Park Medi World IPO Listing at 4% Premium at ₹155.60 Per Share

Posted by : sachet | Wed Dec 17 2025

Park Medi World IPO Listing at 4% Premium at ₹155.60 Per Share

Park Medi World IPO listing: The Park Medi World IPO was subscribed 8.52 times at the time of its closing. In this subscription, qualified institutional buyers (QIBs) received 12.07 times, and non-institutional investors (NIIs) received 15.93 times. The retail quota of the issue was subscribed to 35.00%. Before delving deeper into the topic, go through the details of the Park Medi World IPO.

Park Medi World IPO 

It is a book-building issue of ₹920.00 crore of shares. The issue is entirely a fresh issue of 4.75 crore shares. The IPO is expected to be listed on the BSE and NSE with a tentative listing date of 17th December 2025. The Vidya Wires IPO is expected to take place from 10th December 2025 to 12th December 2025. The face value of Vidya Wires IPO shares is ₹2 per share, and the IPO price is set at ₹162 per share.

IPO Allotment Date15th December 2025
IPO Open Date10th December 2025
IPO Close Date12th December 2025
Refund Initiation 16th December 2025
Issue Size5,67,90,123 shares(aggregating up to ₹920.00 Cr)
Fresh Issue 4,75,30,864 shares(aggregating up to ₹770.00 Cr)
Offer for Sale92,59,259 shares of ₹2(aggregating up to ₹150.00 Cr)
Face Value₹2per share
Lot Size92 Shares
Issue Price ₹154 to ₹162 per share
Issue TypeBookbuilding IPO
Listing AtBSE NSE
Listing Date17th December 2025

Park Medi World IPO Listing

On the BSE platforms, Park Medi World shares are listed at ₹155.60 per share, reflecting a 4% premium over the issue price of ₹162 per share. On the other hand, on the NSE platform, shares are listed at ₹158.80 per share, reflecting a premium of 2% from their issue price of ₹162 per share.

About the Park Medi World IPO 

Park Medi World was established in 2011. Park Medi World Limited is a private hospital chain operating primarily in North India, with a total bed capacity of 3,000 beds as of March 31, 2025. The company operates 14 multi-speciality hospitals under the ‘Park’ brand. All hospitals are accredited by the National Accreditation Board for Hospitals & Healthcare Providers (NABH), and eight are also certified by the National Accreditation Board for Testing and Calibration Laboratories (NABL). The network includes facilities in Haryana, Delhi, Punjab, and Rajasthan. Park Hospital offers more than 30 super speciality and speciality services, such as internal medicine, neurology, urology, gastroenterology, general surgery, orthopaedics, and oncology.

Park Medi World Limited Financials

The company’s financial analysis is essential before applying for Park Medi World Limited’s IPO. Refer to the table to learn about Vidya Wires Limited’s financial information. 

Year Ended30th Sep 2025 (in cr.)31st March 2025 (in cr.)31st March 202431st March 2023
Assets2,320.932,133.701,912.101,592.82
Revenue839.391,425.971,263.081,272.18
Profit After Tax139.14213.22152.01228.19
EBITDA217.14372.17310.30390.34
Net Worth1,153.051,021.86858.63667.55
Reserves and Surplus1,187.771,049.40858.63653.09
Total Borrowings733.91682.07686.71575.68

Explanation

Park Medi World Limited’s revenue increased by 13% from ₹1,263.08 crores in March 2024  to ₹1,425.97 crores in March 2025. Moreover, the company’s PAT increased by 40% from ₹152.01 crores in March 2024 to ₹213.22 crores in March 2025.

Recent Articles

Best Penny Stocks for Long Term in India | Penny Stocks in 2025

Berger Paints Q1 Results FY26: Q1 PAT Narrows 11.01% to ₹314.63 Crore; Revenue Surged 3.55% YoY

Tega Industries Q1 Results FY26: Q1 PAT Falls 3.83% to ₹35.34 Crore; Revenue Jumps 4.74% YoY

Alembic Pharmaceuticals Q1 Results FY26: Q1 PAT Soars 14.60% to ₹154.38 Crore; Revenue Up 9.54% YoY

BLS International Services Q1 Results FY26: Q1 PAT Soars 49.76% to ₹171.00 Crore; Revenue Up 44.23% YoY 

icon

100% Safe & Secure Platform.

Univest encrypts all data and transactions to ensure a completely secure experience for our members.

Copyright

2025 Univest. All rights reserved. | Designed with ❤️ in India
About Univest
About: Univest is a cutting-edge stock market platform designed to help traders and investors maximize their returns with expert-driven advisory services and seamless trading execution. Whether you're a seasoned trader or just starting, Univest simplifies your investment journey with actionable trade recommendations, AI-powered portfolio insights, and a fully integrated brokerage experience. With Univest, you gain access to proven stock market advisory, offering expert trade ideas for stocks, futures, options, and commodities. Our one-click trade execution feature eliminates slippage, ensuring instant execution through our advisory-first brokerage. Smart portfolio management allows you to identify underperforming stocks, optimize your investments, and receive real-time alerts. Additionally, Univest provides seamless investment opportunities beyond stocks, including mutual funds, bonds, fixed deposits, and insurance (coming soon). Join over 40 lakh active investors who trust Univest to make informed and profitable trading decisions. Start investing smarter today! 🚀  
Attention Investors : To ensure a smooth trading experience and prevent unauthorized transactions, investors must update their mobile number and email ID with their stockbroker or depository participant. As per regulatory requirements, investors are required to pay a stipulated amount as an upfront margin for trading in the Cash/FO segment. We encourage all investors to regularly check their securities in the Consolidated Account Statement (CAS) issued by depository to verify their holdings.Always verify alerts and transaction details received directly from the exchange or NSDL before proceeding with any trades. Please do not make payments through unverified email links, WhatsApp, or SMS. Always trade through a registered stockbroker and verify all details before making financial decisions.
 
Disclaimer: Investments in the securities market are subject to market risks. Please read all related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. For more disclaimer /disclosure, visit https://univest.in/stock-broker or Univest App.We collect and use your contact information for legitimate business purposes, including providing updates on our products and services. We do not sell or rent your contact information to third parties. By submitting your details, you authorize us to contact you via Call/SMS, even if you are registered under DND. This authorization remains valid for 12 months.For grievances, please contact us at hello@unibrokers.in .
 
Univest Stock Broking Disclosures
Univest Stock Broking Private Limited - SEBI Reg. No. INZ000317437 (Stock Broker), NSE TM Code: 90392, BSE TM Code: 6866, MCX TM Code: 57290 and ICCL- Self Clearing Member Code: 6866, SEBI Reg. No. IN-DP-779-2024 (Participant), NSDL DP ID: IN304748.
 Risk Disclosures on Derivatives
1. 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
2. On an average, loss makers registered net trading loss close to ₹ 50,000
3. Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
4. Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Attention Investors: As per NSE circular dated July 6, 2022: https://nsearchives.nseindia.com/content/circulars/INSP52900.pdf, BSE circular dated July 6, 2022: https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20220706-55, MCX circular dated July 11, 2022: https://www.mcxindia.com/docs/default-source/circulars/english/2022/july/circular-418-2022.pdf?sfvrsn=9401991_0, investors are cautioned to abstain them from dealing in any schemes of unauthorised collective investments/portfolio management, indicative/ guaranteed/fixed returns / payments etc. 
Investors are further cautioned to avoid practices like:
a. Sharing 
i) trading credentials – login id and passwords including OTPs.
ii) trading strategies,
iii) position details.
b. Trading in leveraged products /derivatives like Options without proper understanding, which could lead to losses.
c. Writing/ selling options or trading in option strategies based on tips, without basic knowledge and understanding of the product and its risks.
d. Dealing in unsolicited tips through platforms like Whatsapp, Telegram, Instagram, YouTube, Facebook, SMS, calls, etc.
e. Trading / Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.
 Kindly read the Advisory Guidelines For Investors as prescribed by the Exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client’s assets: https://nsearchives.nseindia.com/content/circulars/INSP49434.pdf
Kindly, read the advisory as prescribed by the Exchange with reference to their circular: NSE/ISC/51035 dated January 14, 2022 regarding Updation of mandatory KYC fields by March 31, 2022: https://www.nseindia.com/resources/exchange-communication-circulars# 
Attention Investors: Prevent unauthorised transactions in your Demat account by updating your mobile number with your depository participant. Receive alerts on your registered mobile number for debit and other important transactions in your Demat account directly from NSDL on the same day. Prevent unauthorised transactions in your Trading account by updating your mobile numbers/email addresses with your stock brokers. Receive information on your transactions directly from the Exchange on your mobile/email at the end of the day. Issued in the interest of investors. KYC is a one-time exercise while dealing in securities markets - once KYC is done through a SEBI-registered intermediary (Broker, DP), you need not undergo the same process again when you approach another intermediary. As a business, we don’t give stock tips and have not authorised anyone to trade on behalf of others. If you find anyone claiming to be part of Univest Stock Broking Private Limited and offering such services, please send us an email at hello@unibrokers.in
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.
Update your email ID and mobile number with your stockbroker/depository participant and receive an OTP directly from the depository on your registered email ID and/or mobile number. Check your securities/mutual funds/bonds in the Consolidated Account Statement (CAS) issued by NSDL every month.
Attention Investors: SEBI has established an Online Dispute Resolution Portal (ODR Portal) for resolving disputes in the Indian Securities Market. This circular streamlines the existing dispute resolution mechanism, offering online conciliation and arbitration, benefiting investors and listed companies https://www.sebi.gov.in/legal/circulars/jul-2023/online-resolution-of-disputes-in-the- indian-securities-market_74794.html. ODR portal for Investors - https://smartodr.in/login.
Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
General
arrow down